focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSBC Holdings Share News (HSBA)

Share Price Information for HSBC Holdings (HSBA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 697.00
Bid: 697.10
Ask: 697.20
Change: 0.50 (0.07%)
Spread: 0.10 (0.014%)
Open: 694.00
High: 703.20
Low: 688.40
Prev. Close: 696.50
HSBA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-GSK selling $3.45 bln stake in Hindustan Unilever -term sheet

Wed, 06th May 2020 15:03

* GSK cashes in after 2018 Horlicks divestment

* Sells 5.7% stake in Unilever's India business

* GSK had folded Horlicks unit into Hindustan Unilever
(Adds background on GSK, details on deal)

May 6 (Reuters) - GlaxoSmithKline is selling $3.45
billion worth of shares in Unilever's Indian business
on the open market, according to a deal marketing term
sheet seen by Reuters, cashing in late from the sale of the
Horlicks brand.

The 5.7% stake in Hindustan Unilever that is now on the
market, was accepted by GSK as payment for the sale of the
malted drink brand and other nutrition brands to Unilever
, agreed in late 2018.

The shares are being sold for 1,850 to 1,950 rupees, a 3%-8%
discount to Wednesday's close of 2,010.20 rupees, according to
the term sheet.

GSK, which declined to comment, struck a deal to fold its
Indian business - whose main product is Horlicks - into
Unilever's Indian unit Hindustan Unilever in exchange for shares
in the combined group.

Hindustan Unilever also declined to comment.

According to GSK's first-quarter report, it completed the
Horlicks deal on April 1, receiving the 5.7% equity stake in
Hindustan Unilever plus about 400 million pounds ($495
million)in cash.

The cash injection will help GSK in its goal of
reinvigorating its drug development pipeline, having made costly
bets on experimental cancer treatments and future cell and gene
therapies amid sluggish revenue growth.

Earlier this year, GSK launched a two-year programme to
split into two entities, separating the core prescription drugs
and vaccines business from an enlarged over-the-counter products
business that was merged with a Pfizer unit.

It is eyeing more divestments to fund the costs of the
separation.

Having sold travel vaccines to Bavarian Nordic for
up to 955 million euros in October last year, the British group
is looking into shedding more assets, starting with a review of
its prescription dermatology business with about 200-300 million
pounds in annual sales.

IFR earlier reported the Hindustan Unilever
transaction.

The transaction was organised by HSBC, Morgan
Stanley and JP Morgan. They declined to comment.
($1 = 0.8074 pounds)
(Reporting by Anshuman Daga in Singapore, Scott Murdoch and
Sumeet Chatterjee in Hong Kong; Writing by Ludwig Burger;
Editing by Elaine Hardcastle)

More News
1 Sep 2023 00:01

Some UK banks improving interest rates for savers, says watchdog

LONDON, Sept 1 (Reuters) - More savings accounts are offering higher interest rates as a more competitive market emerges, though regulatory intervention may still be needed to ensure customers are getting fair value, Britain's Financial Conduct Authority (FCA) said on Friday.

Read more
30 Aug 2023 12:19

40-year mortgage terms now offered by HSBC UK

(Alliance News) - HSBC Holdings PLC's HSBC UK is offering 40-year mortgages to help people on to or up the property ladder.

Read more
29 Aug 2023 17:27

European shares at two-week high; UK's FTSE 100 outperforms

U.S. job openings data boosts Fed pause bets

*

Read more
29 Aug 2023 12:51

China's Ping An Insurance first-half profit falls 1.2%, retail business weakens

HONG KONG/BEIJING, Aug 29 (Reuters) - Ping An Insurance (Group) Co of China Ltd on Tuesday reported a 1.2% drop in first-half net profit.

Read more
29 Aug 2023 09:27

LONDON BROKER RATINGS: UBS cuts HSBC; Barclays cuts SDCL Energy

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
29 Aug 2023 07:49

LONDON BRIEFING: Bunzl profit up; Rio Tinto sells copper project stake

(Alliance News) - Stocks in London are called to open higher on Tuesday, following a long bank holiday weekend.

Read more
27 Aug 2023 11:37

Saudi Arabia healthcare group Fakeeh Care weighs IPO, appoints HSBC - sources

DUBAI, Aug 27 (Reuters) - Saudi Arabia's Fakeeh Care, one of the largest private hospital groups in the kingdom, is considering selling a 30% stake through an initial public offering (IPO), two sources with knowledge of the matter told Reuters.

Read more
21 Aug 2023 09:24

LONDON BROKER RATINGS: Jefferies raises HSBC price target

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
21 Aug 2023 07:43

LONDON BRIEFING: Crest Nicholson lowers annual profit forecast

(Alliance News) - Stocks in London are called flat on Monday, with little in the way of economic data or company updates to reignite risk appetite.

Read more
18 Aug 2023 17:34

European shares sink to lowest in six weeks, China woes loom large

China-exposed firms fall on growth concerns

*

Read more
18 Aug 2023 10:22

UK banking stocks are undervalued, says Shore Capital

(Sharecast News) - Shore Capital has reiterated its 'buy' ratings on six UK-listed banking stocks, saying the market is currently pricing in a "far worse outlook".

Read more
17 Aug 2023 22:30

Britain makes access to fee-free cash machine a legal right

LONDON, Aug 17 (Reuters) - Nearly everyone in Britain will remain within three miles (4.8 km) of a cash machine that does not charge fees despite the dwindling use of notes and coins, the finance ministry said on Thursday.

Read more
16 Aug 2023 17:33

European shares fall on mounting China worries, banks lag

UK inflation data weighs on FTSE 100

*

Read more
16 Aug 2023 16:55

LONDON MARKET CLOSE: FTSE falls on rate fears and niggling China worry

(Alliance News) - Stock prices in London closed lower on Wednesday, with interest rate-sensitive stocks on the back foot, as a robust core inflation reading poured cold water on hope of a Bank of England pause.

Read more
15 Aug 2023 17:29

Sweden, UK lead European shares lower on rate-hike fears

China-exposed firms drop after weak economic data

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.